i-Target retweeted
Challenges and Opportunities for Pancreatic Cancer Immunotherapy dlvr.it/Rndj8P
i-Target retweeted
#CARTcell Therapie News vom #ASH20. Beim #ASHToday zusammengefasst von Prof. Peter Bader von der Uniklinik Frankfurt, Prof. Andreas Mackensen von der Uniklinik Erlangen, Prof. @MSubklewe vom @LMU_Uniklinikum und Prof. Simone Thomas von der @presse_ukr
👉 ash-today.de!
i-Target retweeted
Congrats to Saskia on her successful PhD defense! One of the pioneers of our antibody subgroup and a great person and scientist!
i-Target retweeted
Check out the poster by our PhD candidate @AnneMarieSenz on how IDO1-deleted CAR T cells show improved therapeutic efficacy in murine pancreatic cancer models @ITOCconference @LMU_Uniklinikum @LMU_Muenchen @iTarget_ENB #Immunotherapy #CARTcells #IDO1 #PancreaticCancer
i-Target retweeted
Welcome to the 7th Immunotherapy of Cancer Virtual Conference! Join us for our welcome address itoc2020.h82.eu/
i-Target retweeted
Excited to hear about Synthetic agonistic receptor-activating BiTEs - a modular platform for the efficient targeting of acute myeloid leukemia from M.Res. Mohamed-Reda Benmebarek @BenmebarekMr on Saturday at @ITOCconference @LMU_Uniklinikum @LMU_Muenchen #Immunotherapy #leukemia
i-Target retweeted
Check out the poster from our medical student Carlotta Rambuscheck: Exploring tumor-intrinsic factors regulating the recruitment of myeloid-derived suppressor cells (MDSC) in pancreatic ductal adenocarcinoma.
Coming soon at @ITOCconference @LMU_Muenchen @LMU_Uniklinikum #ITOC7
i-Target retweeted
Excited to hear Dr. Daniel Böhmer talk on how Gemcitabine induces pro-apoptotic BH3 only proteins and sensitizes pancreatic ductal adenocarcinoma cells for RLH-triggered immunogenic cell death @ITOCconference @LMU_Uniklinikum #PancreaticCancer #Immunotherapy #ITOC7 #CancerTherapy
i-Target retweeted
Check out the poster from Dr. Bruno L. Cadilha @bcadilha : C-C chemokine receptor 8 tumor-directed recruitment enables CAR T cells to reject solid tumors. Coming soon @ITOCconference @LMU_Uniklinikum @LMU_Muenchen #Immunotherapy #CARTcells #ITOC7 #CancerTherapy
i-Target retweeted
Looking forward to Prof. Dr. Sebastian Kobolds talk on why adoptive T cells therapies fail for solid tumors. @ITOCconference on Saturday 3rd of October #Immunotherapy #cancerresearch #ITOC7
itoc-conference.eu/programme
i-Target retweeted
One Week To Go!
Join us for the ITOC7 Virtual Conference on Friday, October 2 and Saturday, October 3, 2020!
itoc-conference.eu
i-Target retweeted
Finally: Onkopedia Guidelines out on „CAR T Zellen: Management von Nebenwirkungen“; Thank you to all the contributors. onkopedia.com/de/onkopedia/g…
i-Target retweeted
In our latest Viewpoint, Lars Koenig (@LM_Koenig) @KlinPharm and colleagues discuss the potential benefits of targeting CXCR2 in COVID-19 treatment. https://teapawt.net/t.co/diiH14rpxi #COVID19
i-Target retweeted
🎉Congratulations!🎉
... to Carolin Daniel from our #IDF for winning the 2020 "Early Career Research Prize in Vaccinology R&D" for her significant achievement in the field of Treg #vaccination in autoimmune #type1diabetes! 👏
➡️iuis.org/news/we-have-a-winn…












